These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21466257)

  • 41. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
    Koeth LM; Good CE; Saunders KA; Jakielaszek C
    Int J Antimicrob Agents; 2004 Aug; 24(2):144-9. PubMed ID: 15288313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrepancy between Vitek 2 and the agar disk method in detecting the amoxicillin-clavulanate resistance in a Klebsiella pneumoniae isolate.
    Savini V; Catavitello C; Balbinot A; Bianco A; Masciarelli G; Astolfi D; D'Antonio D
    Infez Med; 2010 Mar; 18(1):53-4. PubMed ID: 20424528
    [No Abstract]   [Full Text] [Related]  

  • 44. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.
    Villegas MV; Correa A; Perez F; Miranda MC; Zuluaga T; Quinn JP;
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):217-22. PubMed ID: 15246513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.
    Landman D; Babu E; Shah N; Kelly P; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2010 Oct; 65(10):2123-7. PubMed ID: 20667885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative study of a combination of amoxicillin and clavulanic acid and a combination of ticarcillin and clavulanic acid on 249 enterobacteria].
    Aubert G; Lallard P; Dorche G; Denis M
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):651-4. PubMed ID: 3054741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU).
    Yap PS; Ahmad Kamar A; Chong CW; Yap IK; Thong KL; Choo YM; Md Yusof MY; Teh CS
    Pathog Glob Health; 2016 Sep; 110(6):238-246. PubMed ID: 27650884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
    Prakash V; Lewis JS; Herrera ML; Wickes BL; Jorgensen JH
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1278-80. PubMed ID: 19124661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving turnaround time for identifying extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: experience with the BD Phoenix automated system.
    Lebitasy M; Huang TD; Rodriguez-Villalobos H; Simon A
    J Med Microbiol; 2011 May; 60(Pt 5):679-680. PubMed ID: 21233294
    [No Abstract]   [Full Text] [Related]  

  • 59. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1983; 11(6):329-35. PubMed ID: 6365790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.